Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Paradigm | 2025 | Series B | $78.0M | New York |
| Trial Library | 2025 | Series A | $10.0M | San Francisco |
| Erebor | 2025 | Venture - Series Unknown | $350.0M | Columbus |
| Mythic | 2025 | Venture - Series Unknown | $125.0M | Austin |
| Mendra | 2026 | Series A | $82.0M | San Francisco |
| Medra AI | 2025 | Series A | $52.0M | San Francisco |
| Workit Health | 2025 | Grant | Undisclosed | Ann Arbor |
| Variant Bio | 2021 | Series B | Undisclosed | Seattle |
| ZEDEDA | 2025 | Venture - Series Unknown | Undisclosed | San Jose |
| Cajal Neuroscience | 2022 | Series A | Undisclosed | Seattle |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 151 | Paradigm | Series B | $78.0M | New York, United States |
| 152 | Trial Library | Series A | $10.0M | San Francisco, United States |
| 153 | Erebor | Venture - Series Unknown | $350.0M | Columbus, United States |
| 154 | Mythic | Venture - Series Unknown | $125.0M | Austin, United States |
| 155 | Mendra | Series A | $82.0M | San Francisco, United States |
| 156 | Medra AI | Series A | $52.0M | San Francisco, United States |
| 157 | Workit Health | Grant | Undisclosed | Ann Arbor, United States |
| 158 | Variant Bio | Series B | Undisclosed | Seattle, United States |
| 159 | ZEDEDA | Venture - Series Unknown | Undisclosed | San Jose, United States |
| 160 | Cajal Neuroscience | Series A | Undisclosed | Seattle, United States |
Paradigm creates a platform that allow all patients to participate in clinical trials while also enhancing trial efficiency.
Trial Library is an oncology clinical trials company.
A modern bank for the new innovation economy.
Mythic develops analog matrix processors and key cards based on analog compute-in-memory.
Mendra uses AI to accelerate clinical development and commercialization of breakthrough medicines for diseases with high unmet need.
Medra AI develops an autonomous scientific experimentation platform that combines robotics with artificial intelligence.
Workit Health is a virtual-first clinic providing evidence-based, patient-centered treatment for substance use disorders.
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
ZEDEDA is a provider of distributed orchestration and virtualization software for Edge AI Compute.
Cajal Neuroscience is a drug discovery company focused on neurodegenerative disease.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Oasis Labs is a privacy-first cloud computing platform on blockchain technology.
Physical Intelligence is an AI company developing machine learning for robots and other physical devices.
Relativity Space is an aerospace company that designs, develops, and builds 3D printed rockets.
Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Maven is a digital health platform that works with health plans and employers to offer virtual services for women’s and family health.
Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.
Kingdom creates and sells natural functional ingredients that actually work.
Resilience is a biomanufacturing company that provides access to complex medicines and protects biopharmaceutical supply chains.
Rosebud AI Gamemaker. Create Games, Share and Play Instantly Craft Worlds with Words. Go from text description to code to game.
Clarifai's platform supports the full AI development lifecycle; including dataset preparation, model training and deployment.
Build hardware faster. better. together.
SkySelect is a parts procurement services and technology for $100B aircraft material industry
Juicebox provides an AI platform for talent sourcing, recruiting, and engagement.
Atavistik Bio is a biotechnology company that develops precision allosteric small molecules aimed at treating metabolic diseases and cancer.
Lux Capital has invested in 354 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Lux Capital's top investment sectors include Artificial Intelligence (AI), Health Care, Biotechnology, Software, Life Science. The firm invests across 59 different industry categories.
Among tracked funding rounds, Physical Intelligence received $600.0M in a Venture - Series Unknown round. Lux Capital's total known invested capital is $10.5B.
Lux Capital's average investment size is $49.1M across its portfolio of 354 companies.
Recent Lux Capital portfolio additions include Paradigm, Trial Library, Erebor, Mythic, Mendra. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors